Technical Analysis for AIKI - AIkido Pharma Inc.

Grade Last Price % Change Price Change
F 1.03 -4.63% -0.05
AIKI closed down 4.63 percent on Friday, April 9, 2021, on 18 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Down Down
Historical AIKI trend table...

Date Alert Name Type % Chg
Wide Bands Range Expansion 0.00%
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
Down 5 Days in a Row Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Narrow Range Bar Range Contraction -4.63%
NR7 Range Contraction -4.63%
Stochastic Reached Oversold Weakness -4.63%
Wide Bands Range Expansion -4.63%
Down 3 Days in a Row Weakness -4.63%
Older End-of-Day Signals for AIKI ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

AIkido was initially formed in 1967 and is a biotechnology company with a diverse portfolio of small-molecule anti-cancer therapeutics. The Company's platform consists of patented technology from leading universities and researchers and we are currently in the process of developing an innovative therapeutic drug platform through strong partnerships with world renowned educational institutions, including The University of Texas at Austin and Wake Forest University. Our diverse pipeline of therapeutics includes therapies for pancreatic cancer, acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL). In addition, we are constantly seeking to grow our pipeline to treat unmet medical needs in oncology
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Cancer Clinical Medicine Oncology Acute Myeloid Leukemia Leukemia Pancreatic Cancer Acute Lymphoblastic Leukemia Cancer Therapeutics Bemcentinib University Of Texas Camidanlumab Tesirine Causes Of Death University Of Texas At Austin

Is AIKI a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 2.74
52 Week Low 0.4656
Average Volume 14,317,362
200-Day Moving Average 0.91
50-Day Moving Average 1.36
20-Day Moving Average 1.21
10-Day Moving Average 1.13
Average True Range 0.12
ADX 14.49
+DI 18.35
-DI 25.10
Chandelier Exit (Long, 3 ATRs ) 1.07
Chandelier Exit (Short, 3 ATRs ) 1.38
Upper Bollinger Band 1.41
Lower Bollinger Band 1.01
Percent B (%b) 0.06
BandWidth 33.09
MACD Line -0.06
MACD Signal Line -0.05
MACD Histogram -0.012
Fundamentals Value
Market Cap 35.97 Million
Num Shares 34.9 Million
EPS -1.97
Price-to-Earnings (P/E) Ratio -0.52
Price-to-Sales 1241.80
Price-to-Book 0.66
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.12
Resistance 3 (R3) 1.13 1.11 1.11
Resistance 2 (R2) 1.11 1.09 1.11 1.10
Resistance 1 (R1) 1.07 1.07 1.06 1.06 1.09
Pivot Point 1.05 1.05 1.05 1.05 1.05
Support 1 (S1) 1.01 1.03 1.00 1.00 0.97
Support 2 (S2) 0.99 1.01 0.99 0.96
Support 3 (S3) 0.95 0.99 0.96
Support 4 (S4) 0.94